Evidence map›Paper›PMID 31272391›Full record

Trial reportBMC gastroenterology2019

Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study.

Yan Tian, Yan Zhou, Sisi Huang, Jun Li, Kui Zhao, Xiaohui Li, Xiangchen Wen, Xiao-An Li

Registry-linked trialOpen access · goldAbstract readRandomized Controlled TrialClinical Trial, Phase IIClinical Trial, Phase I
In one paragraph

Trial report in BMC gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03016780 (Evaluation of The Effect of Fecal Microbiota Transplantation on Ulcerative Colitis and Its Mechanism), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03016780 phase1 / phase2unknown statusnot on this map

Evaluation of The Effect of Fecal Microbiota Transplantation on Ulcerative Colitis and Its Mechanism

TypeinterventionalSponsorFirst Affiliated Hospital of Chengdu Medical CollegeRan2016 to 2019Enrolled60ConditionsUlcerative Colitis, Intestinal Bacteria Flora Disturbance, Fecal Microbiota TransplantationArmsFecal Microbiota Transplantation, Normal Saline
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Fecal transplantation for treatment of inflammatory bowel disease.The Cochrane database of systematic reviews · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yan TianDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Yan ZhouDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Sisi HuangDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Jun LiDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Kui ZhaoDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Xiaohui LiDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Xiangchen WenDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China.
Xiao-An LiDepartment Of Gastroenterology, The Gastroenterology Tumor and Microenvironment Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Baoguang Road 4, Xindu district, Chengdu, 610041, Sichuan, People's Republic of China. lixiaoancyfy1986@163.com.
First Affiliated Hospital of Chengdu Medical College · CN

Funding

Foundation of the First Affiliated Hospital of Chengdu Medical College ZYFY2017XH04Foundation of the Medical Association of Sichuan Province S16019Innovative Group Foundation of Education Department of Sichuan Province 16TD0028Natural Science Foundation of Education Department of Sichuan Province 16ZA0280Natural Science Foundation of Science and Technology Department of Sichuan Province 2016JY0090Science and Technology Project of The Health Planning Committee of Sichuan 17ZD012
6 · The paper itself

Abstract

backgroundFecal microbiota transplantation may contribute to disease remission in ulcerative colitis; however, the factors that determine the effects of treatment remain unknown. The aim of the present study was to prospectively investigate the clinical efficacy of fecal microbiota transplantation in patients with ulcerative colitis and identify the bacterial signatures associated with clinical remission.

methodsA total of 20 patients with ulcerative colitis were included in this prospective and uncontrolled study. All patients underwent gastroscopy five times, once every 3 weeks. Clinical indices were used to assess the efficacy of fecal microbiota transplantation, as well as the Mayo score, a score used to evaluate the extent of intestinal mucosal lesions in patients with ulcerative colitis. The changes in intestinal flora were detected by 16S ribosomal RNA-sequencing, and the relationship between ulcerative colitis and intestinal flora was analyzed.

resultsAfter treatment, clinical index scores for diarrhea, abdominal pain, and blood stool decreased significantly (p < 0.05). Erythrocyte sedimentation rate and C-reactive protein levels had not changed significantly; however, the clinical index score for intestinal mucosal lesions and the Mayo score decreased significantly. In addition, 16S ribosomal RNA-sequencing revealed that the intestinal flora in patients diagnosed with ulcerative colitis was different from that of donors.

conclusionFecal microbiota transplantation has a potential therapeutic value for the treatment of ulcerative colitis as it changes the abundance of bacterial flora and improves the scores for diarrhea, abdominal pain, and mucous membrane lesions in patients with this disease.

trial registrationThe clinical trial was retrospectively registered with ClinicalTrials.gov ( NCT03016780 ) on January 11th, 2017.

Indexed as

AgedColitis, UlcerativeFecal Microbiota TransplantationFemaleGastrointestinal MicrobiomeHumansMaleMiddle AgedProspective StudiesRemission InductionTreatment OutcomeFecal microbiota transplantationIntestinal floraIntestinal microorganismsUlcerative colitis

Identifiers

PMID31272391
PMCPMC6610864
OpenAlexW2955747826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.